These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 7901023)
21. Linkage disequilibrium between phenylketonuria and RFLP haplotype 1 at the phenylalanine hydroxylase locus in Portugal. Caillaud C; Vilarinho L; Vilarinho A; Rey F; Berthelon M; Santos R; Lyonnet S; Briard ML; Osorio RV; Rey J Hum Genet; 1992 Apr; 89(1):69-72. PubMed ID: 1349566 [TBL] [Abstract][Full Text] [Related]
22. Haplotype analysis of phenylalanine hydroxylase alleles in polish families with phenylketonuria. Jaruzelska J; Borski K; Riess O; Blin N; Słomski R Acta Biochim Pol; 1989; 36(3-4):323-32. PubMed ID: 2577230 [TBL] [Abstract][Full Text] [Related]
23. Progression of cerebral white matter abnormalities in early treated patients with phenylketonuria during adolescence. Weglage J; Bick U; Schuierer G; Pietsch M; Sprinz A; Zass R; Ullrich K Neuropediatrics; 1997 Aug; 28(4):239-40. PubMed ID: 9309716 [TBL] [Abstract][Full Text] [Related]
24. RFLP haplotyping and mutation analysis of the phenylalanine hydroxylase gene in Dutch phenylketonuria families. Meijer H; Jongbloed RJ; Hekking M; Spaapen LJ; Geraedts JP Hum Genet; 1993 Dec; 92(6):588-92. PubMed ID: 7903270 [TBL] [Abstract][Full Text] [Related]
25. Phenylketonuria mutations and their relation to RFLP haplotypes at the PAH locus in Czech PKU families. Kozák L; Kuhrová V; Blazková M; Romano V; Fajkusová L; Dvoráková D; Pijácková A Hum Genet; 1995 Oct; 96(4):472-6. PubMed ID: 7557973 [TBL] [Abstract][Full Text] [Related]
26. Modern techniques of differentiating the various phenotypes of phenylketonuria. Guttler F Postgrad Med J; 1989; 65 Suppl 2():S2-6. PubMed ID: 2576129 [TBL] [Abstract][Full Text] [Related]
27. Prolonged exposure to high and variable phenylalanine levels over the lifetime predicts brain white matter integrity in children with phenylketonuria. Hood A; Antenor-Dorsey JA; Rutlin J; Hershey T; Shimony JS; McKinstry RC; Grange DK; Christ SE; Steiner R; White DA Mol Genet Metab; 2015 Jan; 114(1):19-24. PubMed ID: 25481106 [TBL] [Abstract][Full Text] [Related]
28. Haplotype distribution and mutations at the PAH locus in Croatia. Barić I; Mardesić D; Gjurić G; Sarnavka V; Göbel-Schreiner B; Lichter-Konecki U; Konecki DS; Trefz FK Hum Genet; 1992; 90(1-2):155-7. PubMed ID: 1358784 [TBL] [Abstract][Full Text] [Related]
29. Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations. Leuzzi V; Rinalduzzi S; Chiarotti F; Garzia P; Trasimeni G; Accornero N J Inherit Metab Dis; 1998 Jun; 21(4):351-64. PubMed ID: 9700592 [TBL] [Abstract][Full Text] [Related]
31. White matter pathology in phenylketonuria. Anderson PJ; Leuzzi V Mol Genet Metab; 2010; 99 Suppl 1():S3-9. PubMed ID: 20123467 [TBL] [Abstract][Full Text] [Related]
32. An amino-acid substitution involved in phenylketonuria is in linkage disequilibrium with DNA haplotype 2. DiLella AG; Marvit J; Brayton K; Woo SL Nature; 1987 May 28-Jun 3; 327(6120):333-6. PubMed ID: 2884570 [TBL] [Abstract][Full Text] [Related]
33. Population genetics of hyperphenylalaninaemia resulting from phenylalanine hydroxylase deficiency in Portugal. Rivera I; Leandro P; Lichter-Konecki U; Tavares de Almeida I; Lechner MC J Med Genet; 1998 Apr; 35(4):301-4. PubMed ID: 9598724 [TBL] [Abstract][Full Text] [Related]
34. The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study. Mastrangelo M; Chiarotti F; Berillo L; Caputi C; Carducci C; Di Biasi C; Manti F; Nardecchia F; Leuzzi V Mol Genet Metab; 2015 Nov; 116(3):171-7. PubMed ID: 26283467 [TBL] [Abstract][Full Text] [Related]
35. Mutation analysis of the phenylalanine hydroxylase gene and its clinical implications in two Japanese patients with non-phenylketonuria hyperphenylalaninemia. Kibayashi M; Nagao M; Chiba S J Hum Genet; 1998; 43(4):231-6. PubMed ID: 9852673 [TBL] [Abstract][Full Text] [Related]
36. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome. Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659 [TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of phenylketonuria in Japanese patients. Okano Y; Asada M; Kang Y; Nishi Y; Hase Y; Oura T; Isshiki G Hum Genet; 1998 Nov; 103(5):613-8. PubMed ID: 9860305 [TBL] [Abstract][Full Text] [Related]
38. Phenylketonuria in Spain: RFLP haplotypes and linked mutations. Desviat LR; Pérez B; Ugarte M Hum Genet; 1993 Oct; 92(3):254-8. PubMed ID: 8104860 [TBL] [Abstract][Full Text] [Related]
39. DNA methylated alleles of the phenylalanine hydroxylase promoter remodeled at elevated phenylalanine levels in newborns with hyperphenylalaninemia. Item CB; Farhadi S; Schanzer A; Greber-Platzer S Clin Biochem; 2017 Aug; 50(12):729-732. PubMed ID: 28389235 [TBL] [Abstract][Full Text] [Related]
40. Spasticity and white matter abnormalities in adult phenylketonuria. McCombe PA; McLaughlin DB; Chalk JB; Brown NN; McGill JJ; Pender MP J Neurol Neurosurg Psychiatry; 1992 May; 55(5):359-61. PubMed ID: 1602307 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]